Dr. Giuseppe Lanzino, MD

Dr. Lanzino practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Lanzino's NPI, 1437104551, was assigned on May 24, 2006. Dr. Lanzino graduated from University of Bologna in 1989. Dr. Lanzino holds Minnesota license 50045.

Dr. Lanzino's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Lanzino's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Lanzino is also affiliated with Mayo Clinic Health System in La Crosse. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Lanzino to 1 more hospital, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanzino practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Lanzino's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Lanzino is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Lanzino's licenses on file in 4 states: Minnesota, Illinois, Arizona and Virginia.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Lanzino treats.

CMS data shows 431 Medicare services from Dr. Lanzino across 16 procedure codes in 2024, for 250 Medicare patients. Medicare paid $48,280 for them.

CMS counts 250 Medicare patients who saw Dr. Lanzino in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lanzino's median patient age at 69, with 65% women.

In 2024, Dr. Lanzino wrote 58 Medicare Part D claims for 33 patients. 79% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $27 in total drug cost. In 2023, CMS named 30 claims across 1 drug.

Dr. Lanzino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lanzino as offering telehealth.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 773 papers to Dr. Lanzino, published from 2001 to 2025. 2020 was the busiest year, with 62. The most frequent topics are Intracranial Aneurysm, Embolization, Therapeutic and Endovascular Procedures. Dr. Lanzino has published most often in J Neurosurg. Dr. Lanzino's most frequent co-authors are Harry J. Cloft, MD, Kelly D. Flemming, MD and Lorenzo Rinaldo, MD.

Dmand AI links Dr. Lanzino to 2 clinical trials. Conditions studied include Intracranial Aneurysm, Subarachnoid Hemorrhage and Intracranial Arterial Diseases.

CMS Open Payments shows 24 general payments to Dr. Lanzino from 12 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 87% of the total. Medtronic, Inc. paid the most, $36,275.

Dmand AI lists 1 award for Dr. Lanzino.

Dr. Lanzino graduated from University of Bologna in 1989. Dr. Lanzino is a member of AANS and CNS.

Dr. Lanzino is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.